{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:01:47Z","timestamp":1780315307248,"version":"3.54.1"},"update-to":[{"DOI":"10.1186\/s12879-026-13224-7","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000}}],"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"crossref","award":["C19RM Wave 1"],"award-info":[{"award-number":["C19RM Wave 1"]}],"id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13224-7","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:42:22Z","timestamp":1775562142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED ARTICLE: Seroprevalence of SARS-CoV-2 neutralizing antibodies among travelers entering Ghana through major land borders, pre- and post-opening of borders, 2022"],"prefix":"10.1186","volume":"26","author":[{"given":"Irene","family":"Owusu Donkor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis S.","family":"Lomotey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Odumang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Gafaru","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy A.","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"Kploanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Noora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolphina","family":"Addo-Lartey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Affram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Frimpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalene A.","family":"Odikro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Kenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"13224_CR1","unstructured":"COVID-19 cases | WHO COVID-19 dashboard [Internet]. [cited 2025 Mar 2]. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"13224_CR2","doi-asserted-by":"crossref","unstructured":"Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ. Identifying airborne transmission as the dominant route for the spread of COVID-19. Proc Natl Acad Sci USA [Internet]. 2020 [cited 2025 Jan 14];117:14857\u201363. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7334447\/.","DOI":"10.1073\/pnas.2009637117"},{"key":"13224_CR3","doi-asserted-by":"crossref","unstructured":"Yang Y, Du L, Carver RJ, Yang D. SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies. Signal Transduction and Targeted Therapy 2021 6:1 [Internet]. 2021 [cited 2025 Jan 14];6:1\u20133. Available from: https:\/\/www.nature.com\/articles\/s41392-021-00523-5.","DOI":"10.1038\/s41392-021-00523-5"},{"key":"13224_CR4","doi-asserted-by":"publisher","unstructured":"Bayarri-Olmos R, Idorn M, Rosbjerg A, P\u00e9rez-Al\u00f3s L, Hansen CB, Johnsen LB, et al. SARS-CoV-2 neutralizing antibody responses towards full-length spike protein and the receptor-binding domain. J Immunol. [Internet]. 2021 [cited 2025 Jan 14];207:878\u201387. Available from: https:\/\/doi.org\/10.4049\/jimmunol.2100272.","DOI":"10.4049\/jimmunol.2100272"},{"key":"13224_CR5","unstructured":"WHO Health Emergencies Programme. COVID-19 Cases, African Region [Internet]. WHO COVID-19 dashboard. 2025 [cited 2025 Mar 14]. Available from: https:\/\/data.who.int\/dashboards\/covid19\/cases?m49=953&n=o."},{"key":"13224_CR6","doi-asserted-by":"crossref","unstructured":"Lewis HC, Ware H, Whelan M, Subissi L, Li Z, Ma X, et al. SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. BMJ Glob Health. BMJ Publishing Group; 2022.","DOI":"10.1136\/bmjgh-2022-008793"},{"key":"13224_CR7","doi-asserted-by":"crossref","unstructured":"Kenu E, Odikro MA, Malm KL, Asiedu-Bekoe F, Noora CL, Frimpong JA, et al. Epidemiology of COVID-19 outbreak in Ghana, 2020. Ghana Med J [Internet]. 2020 [cited 2025 Mar 13];54:5. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8087358\/.","DOI":"10.4314\/gmj.v54i4s.3"},{"key":"13224_CR8","unstructured":"Africa Union. AU member countries create history by massively signing the AfCFTA Agreement in Kigali [Internet]. Africa Union Press Releases. 2018 [cited 2025 Mar 13]. Available from: https:\/\/au.int\/en\/pressreleases\/20180321\/au-member-countries-create-history-massively-signing-afcfta-agreement-kigali."},{"key":"13224_CR9","doi-asserted-by":"crossref","unstructured":"Asante IA, Lwanga CN, Takyi C, Sekyi-Yorke AN, Quarcoo JA, Odikro MA, et al. Detection of SARS-CoV-2 variants imported through land borders at the height of the COVID-19 Pandemic in Ghana, 2022. Cureus [Internet]. 2024 [cited 2025 Jan 14];16:e68220. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11439440\/.","DOI":"10.7759\/cureus.68220"},{"key":"13224_CR10","unstructured":"WHO. Capillary Sampling. WHO Guidelines on Drawing Blood: Best Practices in Phlebotomy. 2010."},{"key":"13224_CR11","unstructured":"World Health Organization. Guidance on regulations for the Transport of Infectious Substances the Transport of Infectious Substances. Oms. 2021."},{"key":"13224_CR12","volume-title":"Package insert. Version 2021-01","author":"Beijing Wantai Biological Pharmacy Enterprise Co","year":"2021","unstructured":"Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. WANTAI SARS-CoV-2 NAbs ELISA (WS-1596): Diagnostic kit for neutralizing antibody to SARS-CoV-2 (ELISA). Package insert. Version 2021-01. Beijing: Wantai; 2021."},{"key":"13224_CR13","doi-asserted-by":"crossref","unstructured":"Cromer D, Steain M, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis. Lancet Microbe [Internet]. 2022 [cited 2025 Jan 15];3:e52\u201361. Available from: http:\/\/www.thelancet.com\/article\/S2666524721002676\/fulltext.","DOI":"10.1016\/S2666-5247(21)00267-6"},{"key":"13224_CR14","doi-asserted-by":"crossref","unstructured":"Faraji N, Zeinali T, Joukar F, Aleali MS, Eslami N, Shenagari M, et al. Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies. Heliyon [Internet]. 2024 [cited 2025 Jan 15];10:30208. Available from: http:\/\/www.cell.com\/article\/S240584402406239X\/fulltext.","DOI":"10.1016\/j.heliyon.2024.e30208"},{"key":"13224_CR15","doi-asserted-by":"publisher","unstructured":"Owusu Donkor I, Mensah SK, Dwomoh D, Akorli J, Abuaku B, Ashong Y, et al. Modeling SARS-CoV-2 antibody seroprevalence and its determinants in Ghana: A nationally representative cross-sectional survey. PLOS Global Public Health [Internet]. 2023;3:e0001851. Available from: https:\/\/doi.org\/10.1371\/journal.pgph.0001851.","DOI":"10.1371\/journal.pgph.0001851"},{"key":"13224_CR16","doi-asserted-by":"crossref","unstructured":"Quashie PK, Mutungi JK, Dzabeng F, Oduro-Mensah D, Opurum PC, Tapela K, et al. Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana. Wellcome Open Res [Internet]. 2021;6:173. Available from: https:\/\/wellcomeopenresearch.org\/articles\/6-173\/v1.","DOI":"10.12688\/wellcomeopenres.16890.1"},{"key":"13224_CR17","doi-asserted-by":"crossref","unstructured":"Zaballa ME, Perez-Saez J, de Mestral C, Pullen N, Lamour J, Turelli P, et al. Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study. The Lancet Regional Health - Europe [Internet]. 2022 [cited 2025 Jan 16];24:100547. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9714630\/.","DOI":"10.1101\/2022.07.27.22278126"},{"key":"13224_CR18","doi-asserted-by":"crossref","unstructured":"Gorse GJ, Donovan MM, Patel GB. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. J Med Virol [Internet]. 2020 [cited 2025 Jan 16];92:512. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7166442\/.","DOI":"10.1002\/jmv.25715"},{"key":"13224_CR19","doi-asserted-by":"publisher","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. New England Journal of Medicine [Internet]. 2021 [cited 2024 Sep 29];384:403\u201316. Available from: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa2035389.","DOI":"10.1056\/NEJMoa2035389"},{"key":"13224_CR20","doi-asserted-by":"crossref","unstructured":"Aguilera X, Gonz\u00e1lez C, Apablaza M, Rubilar P, Icaza G, Ram\u00edrez-Santana M, et al. Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile. Vaccines (Basel) [Internet]. 2022 [cited 2025 Jan 16];10:1002. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9322351\/.","DOI":"10.3390\/vaccines10071002"},{"key":"13224_CR21","unstructured":"Thompson MG, Natarajan K, Irving SA, Rowley EA, Griggs EP, Gaglani M, et al. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep [Internet]. 2022 [cited 2025 Jan 16];71:139\u201345. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35085224\/."},{"key":"13224_CR22","doi-asserted-by":"crossref","unstructured":"Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med [Internet]. 2021 [cited 2025 Jan 16];384:1412\u201323. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33626250\/.","DOI":"10.1056\/NEJMoa2101765"},{"key":"13224_CR23","doi-asserted-by":"crossref","unstructured":"Colmenares-Mej\u00eda CC, Serrano-D\u00edaz N, Quintero-Lesmes DC, Meneses L, Acosta IS, Idrovo \u00c1J, et al. Seroprevalence of SARS-CoV-2 Infection among Occupational Groups from the Bucaramanga Metropolitan Area, Colombia. Int J Environ Res Public Health [Internet]. 2021 [cited 2025 Jan 16];18. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33920843\/.","DOI":"10.3390\/ijerph18084172"},{"key":"13224_CR24","doi-asserted-by":"crossref","unstructured":"Vos ERA, Van Boven M, Den Hartog G, Backer JA, Klinkenberg D, Van Hagen CCE, et al. Associations between measures of social distancing and severe acute respiratory syndrome coronavirus 2 seropositivity: a nationwide population-based study in the Netherlands. Clin Infect Dis [Internet]. 2021 [cited 2025 Jan 16];73:2318\u201321. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33772265\/.","DOI":"10.1093\/cid\/ciab264"},{"key":"13224_CR25","unstructured":"Ghana Health Service. COVID-19: Vaccine distribution [Internet]. COVID-19 Updates | Ghana. 2023 [cited 2025 Mar 14]. Available from: https:\/\/ghs.gov.gh\/covid19\/#."},{"key":"13224_CR26","doi-asserted-by":"crossref","unstructured":"Taylor KM, Ricks KM, Kuehnert PA, Eick-Cost AA, Scheckelhoff MR, Wiesen AR, et al. Seroprevalence as an indicator of undercounting of COVID-19 cases in a large well-described cohort. AJPM Focus [Internet]. 2023 [cited 2025 Mar 14];2:100141. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10598697\/.","DOI":"10.1016\/j.focus.2023.100141"}],"updated-by":[{"DOI":"10.1186\/s12879-026-13224-7","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13224-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13224-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13224-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:31:16Z","timestamp":1779795076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13224-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13224"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13224-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clarification","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was retracted on 21 May 2026.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1034"}}